Mehmet Huyut-Tahir

Erzincan, 24000, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Author Correction: Identification of right ventricular dysfunction with LogNNet based diagnostic model: A comparative study with supervised ML algorithms.

Author Correction: Identification of right ventricular dysfunction with LogNNet based diagnostic model: A comparative study with supervised ML algorithms.

Journal: Scientific reports

Published: December 24, 2025

Identification of right ventricular dysfunction with LogNNet based diagnostic model: A comparative study with supervised ML algorithms.

Identification of right ventricular dysfunction with LogNNet based diagnostic model: A comparative study with supervised ML algorithms.

Journal: Scientific reports

Published: January 07, 2025

Clinical decision support system for detecting right ventricular dysfunction in acute pulmonary embolism: Explainable a new Binary Rule Search (BRS) ensembles and robustness evaluation.

Clinical decision support system for detecting right ventricular dysfunction in acute pulmonary embolism: Explainable a new Binary Rule Search (BRS) ensembles and robustness evaluation.

Journal: Artificial intelligence in medicine

Published: January 07, 2025

Corrigendum to "What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?" [Int. Immunopharmacol. 105 (2022) 108542].

Corrigendum to "What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?" [Int. Immunopharmacol. 105 (2022) 108542].

Journal: International immunopharmacology

Published: January 01, 2025

Corrigendum to "Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19" [Int. Immunopharmacol. 100 (2021) 108127].

Corrigendum to "Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19" [Int. Immunopharmacol. 100 (2021) 108127].

Journal: International immunopharmacology

Published: November 22, 2024

Alleviation of LPS-induced acute lung injury by propolis-based nanocomposites through the TLR4/NFKB and P2X7/AKT pathways: Randomized-controlled experimental study.

Alleviation of LPS-induced acute lung injury by propolis-based nanocomposites through the TLR4/NFKB and P2X7/AKT pathways: Randomized-controlled experimental study.

Journal: Toxicon : official journal of the International Society on Toxinology

Published: October 09, 2024

Corrigendum to "The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease" [Int. Immunopharmacol. 98 (2021) 107838].

Corrigendum to "The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease" [Int. Immunopharmacol. 98 (2021) 107838].

Journal: International immunopharmacology

Published: September 04, 2023

Corrigendum to "What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?" [Int. Immunopharmacol. 105 (2022) 108542].

Corrigendum to "What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?" [Int. Immunopharmacol. 105 (2022) 108542].

Journal: International immunopharmacology

Published: August 25, 2023

A new treatment approach: Melatonin and ascorbic acid synergy shields against sepsis-induced heart and kidney damage in male rats.

A new treatment approach: Melatonin and ascorbic acid synergy shields against sepsis-induced heart and kidney damage in male rats.

Journal: Life sciences

Published: May 15, 2023

Corrigendum to "Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19" [Int. Immunopharmacol. 100 (2021) 108127].

Corrigendum to "Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19" [Int. Immunopharmacol. 100 (2021) 108127].

Journal: International immunopharmacology

Published: November 20, 2022

What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?

What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?

Journal: International immunopharmacology

Published: November 14, 2021

Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19.

Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19.

Journal: International immunopharmacology

Published: June 27, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026